May 15, 2019 / 10:40PM GMT
Ashwani Verma - BofA Merrill Lynch, Research Division - Research Analyst
Our next company is Amphastar Pharmaceuticals. And with me is President, Jason Shandell. My name is Ashwani Verma. I'm with the U.S. major and specialty pharmaceuticals team with the Bank of America.
And Jason, just over to you. Let's take a look at the slides.
Jason B. Shandell - Amphastar Pharmaceuticals, Inc. - President, General Counsel & Director
Great. Great. Thank you. So I'll just get the light -- okay, there we go. So just going to go through the slides. I know we only have a short amount of time and then can open it up for some quick Q&A.
And so let's go through the forward-looking statements. So essentially, Amphastar, we're headquartered in Rancho Cucamonga. That's east of downtown L.A., about 1 hour. We're very well known for enoxaparin -- is still one of our largest revenue products. We were approved in 2011, have always been proud of that approval. It really is a testament to our scientific capabilities with characterization and immunogenicity.
Amphastar Pharmaceuticals Inc at Bank of America Merrill Lynch Health Care Conference Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers